跳至主要内容
临床试验/NL-OMON56961
NL-OMON56961尚未招募不适用

Cost-effectiveness of schema therapy for treatment-resistant anxiety disorders: A multicentre RCT - Schema therapy for anxiety

Amsterdam UMC0 个研究点目标入组 172 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age 18-65
  • - Primary diagnosis of an anxiety disorder (panic disorder, agoraphobia, social
  • anxiety disorder, generalised anxiety disorder, separation anxiety disorder and
  • specific phobia) according to DSM-5.
  • - Fulfilling criteria of treatment-resistance based on a systematic literature
  • search i) at least one unsuccessful cognitive behavioural therapy (CBT) trial
  • of >= 8 weeks; and ii) at least one unsuccessful pharmacological treatment with
  • a serotonergic antidepressant of >= 8 weeks OR valid reasons for not wanting to
  • or not being able to receive medication, and iii) moderate to severe anxiety
  • symptoms (Beck Anxiety Inventory score > 11). Adequacy of previous treatment
  • will be checked.

排除标准

  • Substance use dependence
  • Acute suicidality
  • Received schema therapy in the past
  • Insufficient Dutch or English

研究者

发起方
Amsterdam UMC

相似试验